TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 46 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $579,000 | -16.5% | 346,719 | 0.0% | 0.03% | -19.4% |
| Q2 2022 | $693,000 | -24.0% | 346,719 | 0.0% | 0.04% | +38.5% |
| Q1 2022 | $912,000 | -5.0% | 346,719 | +0.0% | 0.03% | +36.8% |
| Q4 2021 | $960,000 | -28.5% | 346,718 | 0.0% | 0.02% | +18.8% |
| Q3 2021 | $1,342,000 | -40.4% | 346,718 | 0.0% | 0.02% | -44.8% |
| Q2 2021 | $2,250,000 | -92.1% | 346,718 | 0.0% | 0.03% | -95.5% |
| Q1 2021 | $28,535,000 | +603.4% | 346,718 | 0.0% | 0.64% | +498.1% |
| Q4 2020 | $4,057,000 | +126.3% | 346,718 | 0.0% | 0.11% | +40.8% |
| Q3 2020 | $1,793,000 | +163.7% | 346,718 | 0.0% | 0.08% | +181.5% |
| Q2 2020 | $680,000 | +15.4% | 346,718 | 0.0% | 0.03% | -12.9% |
| Q1 2020 | $589,000 | – | 346,718 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,764,508 | $848,082 | 0.28% |
| Ikarian Capital, LLC | 2,765,530 | $492,265 | 0.06% |
| JOHNSON & JOHNSON | 84,003 | $14,953 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $46,074 | 0.00% |
| BlackRock Inc. | 267,821 | $47,673 | 0.00% |
| Bank of New York Mellon Corp | 10,259 | $1,826 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,835 | $2,819 | 0.00% |
| Truvestments Capital LLC | 318 | $57 | 0.00% |
| Tower Research Capital LLC (TRC) | 10,407 | $1,852 | 0.00% |
| Cutler Group LLC / CA | 1,200 | $0 | 0.00% |